secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001437749-24-037475
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics receives Nasdaq bid price deficiency notice; has until June 10, 2025 to comply
--------------------------------------------------------------------------------

- Nasdaq notice dated Dec 12, 2024: common stock bid price below $1.00 for 31 consecutive business days.
- Company has 180 calendar days, until June 10, 2025, to regain compliance under Nasdaq Listing Rule 5810(c)(3)(A).
- To regain compliance, closing bid price must be $1.00 or more for at least ten consecutive business days.
- If not cured by June 10, 2025, Company may seek a second 180-day period if meeting all other initial listing standards and intends a reverse stock split.
- Failure to regain compliance or secure extension could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924037475/0001437749-24-037475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774924037475/ekso20241212_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-037475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer